TY - JOUR
KW - Dipeptidyl peptidase-4 inhibitors
KW - active-comparator
KW - and Inflammatory Bowel Disease
KW - causal inference
KW - new-user
KW - pharmacoepidemiology
KW - study design
KW - switcher
KW - time-varying exposure
KW - trial emulation
AU - T. Wang
AU - J. Wang
AU - Z. Song
AU - E. Miller
AU - V. Pate
AU - Q. Her
AU - J. Yang
AU - S. Charlier
AU - P. Egger
AU - E. Barnes
AU - J. Buse
AU - C. Becker
AU - R. Sandler
AU - C. Meier
AU - S. Jick
AU - T. Sturmer
AD - Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States.
Global Epidemiology, GSK, Collegeville, PA, USA.
Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.
Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, United States.
Division of Endocrinology and Metabolism, Department of Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, United States.
Boston Collaborative Drug Surveillance Program, Lexington, Massachusetts, United States.
AN - 40069957
BT - Am J Epidemiol
DO - 10.1093/aje/kwaf044
DP - NLM
ET - 2025/03/12
LA - eng
N1 - 1476-6256
Wang, Tiansheng
Wang, Jeanny
Song, Zoey
Miller, Elyse
Pate, Virginia
Her, Qoua
Yang, Jeff
Charlier, Sarah H R
Egger, Pascal
Barnes, Edward L
Buse, John B
Becker, Claudia
Sandler, Robert S
Meier, Christoph
Jick, Susan
Stürmer, Til
Journal Article
United States
Am J Epidemiol. 2025 Mar 5:kwaf044. doi: 10.1093/aje/kwaf044.
PY - 2025
SN - 0002-9262
T2 - Am J Epidemiol
TI - Caution in Handling Switchers in Pharmacoepidemiologic Studies Estimating Treatment Effects: The Example of Dipeptidyl Peptidase-4 Inhibitors and Inflammatory Bowel Disease
ER -